AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SMEDAL, M. I.
Right arrow Articles by MEISSNER, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SMEDAL, M. I.
Right arrow Articles by MEISSNER, W. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 99, 352-364, Copyright © 1967 by American Roentgen Ray Society

THE VALUE OF 2 MV. ROENTGEN-RAY THERAPY IN DIFFERENTIATED THYROID CARCINOMA

MAGNUS I. SMEDAL M.D.1, FERDINAND A. SALZMAN M.D.1, and WILLIAM A. MEISSNER M.D.2

1 Department of Radiotherapy, Lahey Clinic Foundation
2 Department of Pathology, New England Deaconess Hospital, Boston, Massachusetts

Papillary and follicular carcinoma of the thyroid is radiosensitive. The survival rate of 82 per cent for 5 years in surgically non-resectable cases using external radiation as the prime modality is equal to our results with radical surgery plus megavolt external radiation. The high 5 year survival rate in the limited number of cases in Stage I and Stage II suggests that radical surgery is not necessary.

The addition of external radiation should be reserved for cases in which surgery has not eradicated the known disease or in lieu of radical neck dissection when residual disease is known or suspected.

Our experience continues to show that better results are obtained with supervoltage than with orthovoltage radiation, primanly because we are able to deliver twice the dosage with fewer local reactions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1967 by the American Roentgen Ray Society.